LATEST NEWS
- Institute News
Northern Trust wealth management executive Paul Thiel joins Institute Board
- Research News
Detailed structural studies provide blueprint for the development of potent therapeutics and vaccines
- Research News
LJI researchers reveal how the finely tuned balance between DNA methylation and demethylation prevents genomic instability and cancer
- Research News
LJI team finds that ‘doublet’ immune cells are much more common—and more important in disease—than previously thought
- Research News
LJI’s new understanding of killer T cells inspires clinical studies of potential immunotherapies
- Institute News
Former President of Cardinal Health China and long-term supporter of the Institute’s mission brings international healthcare expertise and a passion for life sciences
- Institute News
The grant establishes the global Viral Immunotherapeutic Consortium to develop new treatments for Ebola, Lassa and other viral threats
- Institute News
La Jolla Institute mourns passing of former Board member
- Institute News
LJI’s Clinical Associates Program emerged from the recognition that the clinic is an extension of the lab
- Research News
LJI scientists find that slowly releasing an HIV vaccine could prompt the body to make more powerful antibodies against the virus
- Research News
New study reveals how a subset of T cells morphs from peacemaker to rabble-rouser when TET activity is lost
